Indefinite Delivery Contract SPE2DM20D0706

The provided information details an Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) to Cardinal Health 200, LLC, a subsidiary of Cardinal Health, Inc. The single-award IDC, valued up to $4,999,999, enables the rapid procurement of a wide range of medical and pharmaceutical products under Federal Supply Group 46 and Federal Supply Class 6515. This includes surgical dressings, drugs, biologicals, and other medical consumables to support military treatment facilities and Department of Defense customers in DLA Region 1. The contract has an effective period through August 2027, allowing for the issuance of delivery orders as needed to meet the ongoing medical supply requirements of the military healthcare system. Cardinal Health 200, LLC, as a major supplier of medical and pharmaceutical products to the U.S. federal government, leverages its parent company's extensive experience in healthcare distribution and manufacturing to fulfill these critical procurement needs. This flexible contracting vehicle demonstrates Cardinal Health 200, LLC's role as a key player in the federal healthcare supply chain, providing essential products efficiently and at scale to support military and civilian healthcare providers.

In addition to the IDC awarded by DLA, the information also highlights other significant federal contract awards held by Cardinal Health, Inc. and its subsidiaries. These include a single-award IDV with the Department of Veterans Affairs for the provision of radiopharmaceutical products, as well as a separate IDC awarded to The Harvard Drug Group, L.L.C. (a Cardinal Health subsidiary) for the supply of Lurasidone Hydrochloride tablets. These specialized contracts further demonstrate Cardinal Health's capability to manage large-scale, multi-agency pharmaceutical supply agreements and handle time-sensitive, radioactive medical products crucial for diagnostic imaging in VA medical facilities.